The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine - Muller, N; Schwarz, M J; Dehning, S (Mol Psychiatry, 2006)
et al.